Literature DB >> 20644156

Motor tics, stereotypies, and self-flagellation in primrose syndrome.

P Dalal1, N D Leslie, N M Lindor, D L Gilbert, A J Espay.   

Abstract

Mesh：

Year:  2010        PMID： 20644156      PMCID： PMC3463006          DOI： 10.1212/WNL.0b013e3181e8e754

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  The Primrose syndrome with progressive neurological involvement and cerebral calcification.

Authors:  Carla Battisti; Maria Teresa Dotti; Alfonso Cerase; Alessandra Rufa; Francesco Sicurelli; Chiara Scarpini; Antonio Federico
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

Review 2.  Tardive tourettism after exposure to neuroleptic therapy.

Authors:  K J Bharucha; K D Sethi
Journal:  Mov Disord       Date:  1995-11       Impact factor: 10.338

3.  A slowly progressive degenerative condition characterized by mental deficiency, wasting of limb musculature and bone abnormalities, including ossification of the pinnae.

Authors:  D A Primrose
Journal:  J Ment Defic Res       Date:  1982-06

Review 4.  A neuropsychiatric disorder associated with dense calcification of the external ears and distal muscle wasting: 'Primrose syndrome'.

Authors:  N M Lindor; A D Hoffman; D A Primrose
Journal:  Clin Dysmorphol       Date:  1996-01       Impact factor: 0.816

5.  The syndrome of mental handicap, cataracts, muscle wasting and skeletal abnormalities: report of a second case.

Authors:  R A Collacott; B P O'Malley; I D Young
Journal:  J Ment Defic Res       Date:  1986-09

Review 6.  Testicular cancer in a patient with Primrose syndrome.

Authors:  Inge B Mathijssen; Jos van Hasselt-van der Velde; Raoul C M Hennekam
Journal:  Eur J Med Genet       Date:  2005-06-23       Impact factor: 2.708

7.  Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies.

Authors:  Mark J Edwards; Russell C Dale; Andrew J Church; Eleni Trikouli; Niall P Quinn; Andrew J Lees; Gavin Giovannoni; Kailash P Bhatia
Journal:  Mov Disord       Date:  2004-10       Impact factor: 10.338
  7 in total
  4 in total

1.  Mutations in ZBTB20 cause Primrose syndrome.

Authors:  Viviana Cordeddu; Bert Redeker; Emilia Stellacci; Aldo Jongejan; Alessandra Fragale; Ted E J Bradley; Massimiliano Anselmi; Andrea Ciolfi; Serena Cecchetti; Valentina Muto; Laura Bernardini; Meron Azage; Daniel R Carvalho; Alberto J Espay; Alison Male; Anna-Maja Molin; Renata Posmyk; Carla Battisti; Alberto Casertano; Daniela Melis; Antoine van Kampen; Frank Baas; Marcel M Mannens; Gianfranco Bocchinfuso; Lorenzo Stella; Marco Tartaglia; Raoul C Hennekam
Journal:  Nat Genet       Date:  2014-07-13       Impact factor: 38.330

2.  Zbtb20 Restrains CD8 T Cell Immunometabolism and Restricts Memory Differentiation and Antitumor Immunity.

Authors:  Yanbo Sun; Nicholas K Preiss; Kristine B Valenteros; Yasmin Kamal; Young-Kwang Usherwood; H Robert Frost; Edward J Usherwood
Journal:  J Immunol       Date:  2020-09-30       Impact factor: 5.422

3.  The effect of homozygous deletion of the BBOX1 and Fibin genes on carnitine level and acyl carnitine profile.

Authors:  Ali Rashidi-Nezhad; Saeed Talebi; Homeira Saebnouri; Seyed Mohammad Akrami; Alexandre Reymond
Journal:  BMC Med Genet       Date:  2014-07-01       Impact factor: 2.103

4.  Primrose syndrome: Characterization of the phenotype in 42 patients.

Authors:  Daniela Melis; Daniel Carvalho; Tina Barbaro-Dieber; Alberto J Espay; Michael J Gambello; Blanca Gener; Erica Gerkes; Marrit M Hitzert; Hanne B Hove; Sandra Jansen; Petr E Jira; Katherine Lachlan; Leonie A Menke; Vinodh Narayanan; Damara Ortiz; Eline Overwater; Renata Posmyk; Keri Ramsey; Alessandro Rossi; Renata Lazari Sandoval; Constance Stumpel; Kyra E Stuurman; Viviana Cordeddu; Peter Turnpenny; Pietro Strisciuglio; Marco Tartaglia; Sheela Unger; Todd Waters; Clare Turnbull; Raoul C Hennekam
Journal:  Clin Genet       Date:  2020-04-20       Impact factor: 4.438
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.